drugset / Trial / NCT00630045
Phase 3 Study of Surgery Combined With Neoadjuvant Chemotherapy(XELOX) in Colorectal Cancer With Resectable Liver Metastasis
Phase 3
Unknown
392 enrolled
Peking University People's Hospital
Peking University · collabSanofi · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
This study aims to discuss the efficacy and safety of neoadjuvant chemotherapy with XELOX regimen (oxaliplatin plus capecitabine) .
Timeline
- Start
- 2008-01
- Primary completion
- 2010-06
- Completion
- 2015-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Capecitabine | Small molecule | 1000 mg/m2 | — |
| Subject | Oxaliplatin | Small molecule | 130 mg/m2 | — |